Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for ...

REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

Capsugel Investing More Than $25 Million in Increased Production Capacity and Quality Enhancements for its Industry-Leading Vegetarian Capsule Portfolio Morristown, N.J., March 26, 2015 – Capsugel, a ...

Morristown, N.J. – April 28, 2014 – Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel's Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only ...

Drug delivery solutions company Capsugel said Tuesday it has completed the acquisitions of two companies announced late last year.The finalization of the deals for Xcelience and Powdersize means the ...

Private equity firm KKR will buy Pfizer’s Capsugel business for $2.375 billion in cash, the firms revealed Monday morning in a joint statement. Capsugel generated about $750 million in revenue in 2010 ...

Pfizer, which recently told Wall Street it planned to slim down its business, said it would sell off capsule-maker Capsugel to the private equity group KKR for nearly $2.38 billion. Capsugel makes a ...

Capsugel has announced that it has completed its acquisitions of Xcelience and Powdersize. Xcelience and Powdersize are now part of Capsugel's Dosage Form Solutions business unit, which partners with ...

Capsugel and Bend Research have announced that they have entered into a definitive agreement for Capsugel to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The ...

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions. In the latest development in a busy year of mergers and acquisitions in the ...

A logo is pictured on the laboratory building on the Lonza site in Visp, western Switzerland September 10, 2013. REUTERS/Denis Balibouse 32,785 people played the daily Crossword recently. Can you ...